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ABSTRACT 
In this study, the selective crystallization and characterization of the stoichiometric forms 
of the p-Toluenesulfonamide/Triphenylphosphine oxide (p-TSA-TPPO) co-crystal system in 
acetonitrile (MeCN) is demonstrated using batch and semi-batch crystallizers. In the batch 
study, both 1:1 and 3:2 p-TSA-TPPO were successfully isolated as pure forms. However, 
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process variability was observed in a few experimental runs. To address the batch process 
variability issue, a control strategy was implemented using temperature cycling, aided by in 
situ process analytical technologies (PAT) to convert from 3:2 to 1:1 p-TSA-TPPO. In the 
semi-batch co-crystallization studies, the two molecular co-formers, p-TSA and TPPO, were 
dissolved in MeCN and pumped separately to the crystallizer. Changing the flow rates of the 
respective active ingredients allowed control over the co-crystallization outcome, and 
presents as a promising opportunity for development of a continuous co-crystallization 
process. 
Keywords: Co-crystallization, Co-crystal, Stoichiometric, Process Analytical Technologies 
1. INTRODUCTION 
In the agrochemical industry there is a need for the development and application of new 
active ingredient design strategies to deliver solutions for the discovery of agrochemicals that 
are fit for purpose in the 21
st
 century [1]. For example, there is a need to reduce absolute 
usage of active agrochemical ingredients (AAIs) to minimise environmental impact. To 
achieve this, a structure-based design approach to AAI production is required. Structure-
based design is an iterative and multi-disciplinary process that is well established in the 
pharmaceutical industry [2]. It has played an important role in the development of several 
registered drugs and clinical candidates [1], [2], for example, zanamivir [3], lopinavir–
ritonavir and nelfinavir [4]. In contrast, structure-based design is a relatively new concept in 
the agrochemical industry, and there are currently no products on the market that are the 
direct result of this approach [1]. In recent years structure-based design of multi-component 
molecular systems has gained popularity in the pharmaceutical sector as a viable alternative 
to traditional design approaches used to modify active pharmaceutical ingredients (APIs) for 
more effective performance. Modifications of the structure and molecular composition of an 
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active ingredient by applying structure-based design principles can lead to significant 
improvements to the stability, solubility and release profile. This could lead to a reduction in 
use rates of AAIs, and hence a minimised environmental impact. For example, the release 
profile of an AAI could be controlled through the design of multi-component molecular 
entities such as co-crystals. Furthermore, multi-component systems offer the opportunity to 
delivery not just one, but two or more AAIs simultaneously, which could potentially 
minimize operating cost and equipment foot print through simplification of manufacturing 
processes. 
The definition of a co-crystal has been widely debated in the scientific community [5], [6], 
however, there is now a general consensus since the publication of FDA guidelines [7] that a 
co-crystal is a crystalline multi-component molecular entity made up of two or more 
components in a definite stoichiometric ratio. Co-crystallization can be an effective crystal 
engineering approach for modifying the crystal structure and properties of an active 
ingredient [8], [9]. However, many of the current methods used to isolate co-crystal forms 
such as neat and liquid assisted grinding [10], [11], slurry conversion [12], [13], supercritical 
fluid enhanced atomization [14], and evaporative co-crystallization [13], [15], [16] cannot be 
scaled to industrial production capacity. Cooling crystallization is perhaps the most viable 
route to scale-up, yet there are only a few studies that have explored this method to isolate 
co-crystals [17]–[19]. There are even fewer studies that are carried out using large scale 
laboratory crystallizers (that is, 500 – 1L capacity) [17], [18]. In addition, there is limited use 
of process analytical technologies (PAT) to monitor, control and characterize co-
crystallization processes [16], [18]. 
In this study, the co-crystallization of two model AAIs, p-Toluenesulfonamide (p-TSA) and 
Triphenylphosphine oxide (TPPO) is demonstrated as part of a proof of concept study using 
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laboratory scale (500 mL) batch and semi-batch crystallizers. The aim of this study is to 
monitor, control and fully characterize the crystalline forms of the resulting multi-component 
AAI co-crystals using an integrated array of PAT tools, crystallization process informatics 
systems (CryPRINS) software, and off-line solid state characterization techniques. p-TSA 
and its derivatives are widely used as raw materials for the synthesis of pesticides, drugs and 
fluorescent colorants [20], [21]. There are two known polymorphs of p-TSA, α form 
(monoclinic) differs from the β form (triclinic), which has a unusual arrangement of layers 
[22]. TPPO finds use in the production of crop protection products, anti-fungal coatings, 
vitamins, and APIs [23], [24]. There are three known polymorphic forms of TPPO [25], [26], 
one orthorhombic and two monoclinic forms. Etter and Baures [26] were amongst the first to 
isolate co-crystals of TPPO. They were able to successfully co-crystallized TPPO with 15 
different molecular entities, inclusive of several derivatives of p-TSA.  
There are two known stoichiometric forms of the p-TSA-TPPO co-crystal system 
composed of 1:1 and 3:2 mole ratios of p-TSA and TPPO respectively. There are no known 
polymorphic forms of these two stoichiometric co-crystal forms. Glidewell et al. [27], [28] 
isolated the 3:2 form of p-TSA-TPPO and reported on the crystal and molecular structures. 
The authors used a small scale reactive crystallization method whereby triphenylphosphine 
(TPP) was reacted with Chloramine-T(n-chloro p-toluenesulfonamide sodium salt) in 
ethanol; the product was then recrystallized from anhydrous benzene. Croker et al. [13] 
isolated and reported the crystal structure of the 1:1 form of p-TSA-TPPO. In their work solid 
state grinding and small scale evaporative (10 mL) and cooling (50 mL) crystallization 
methods were applied. They also constructed two ternary phase diagrams at 20 
o
C for the two 
co-former molecules (p-TSA and TPPO) in acetonitrile (MeCN) and dichloromethane 
(CH2Cl2) solvents respectively. Subsequent studies examined the nucleation behavior [29], 
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isothermal suspension conversion [6] and solution-mediated phase transformation [30] of the 
two co-crystal forms. 
In this study, a control strategy employing a temperature cycling approach was 
implemented in the batch cooling co-crystallization process where variability was detected. 
This was aided by an integrated array of PAT tools consisting of Raman, attenuated total 
reflectance ultra-violet/visible (ATR-UV/vis) and Fourier transform infrared (ATR-FTIR) 
spectroscopy, focused beam reflectance measurement (FBRM) and particle vision 
microscopy (PVM) with complementary solid state characterization techniques were used for 
intelligent decision support (IDS) and control of the co-crystallization processes using the 
crystallization process informatics system (CryPRINS). Complementary off-line solid state 
characterization techniques, comprising powder x-ray diffraction (PXRD), differential 
scanning calorimetry (DSC), hot stage microscopy (HSM), scanning electron 
microscopy/energy dispersive spectroscopy (SEM), Raman microscopy and FTIR 
spectroscopy were used for phase identification. In the semi-batch operation, a flow rate 
control strategy also aided by PAT and off-line analysis, whereby the two co-formers are 
dissolved and pumped separately to a crystallizer unit was demonstrated as a viable option for 
controlling the co-crystallization outcome.  This approach shows promise for further 
development into a continuous co-crystallization process. The batch and semi-batch co-
crystallization studies at a larger scale (500 mL) compared to previous works to examine the 
scalability of the p-TSA-TPPO system. A further aim of the study is to monitor and control 
the selective co-crystallization of the 1:1 and 3:2 co-crystal forms of the p-TSA-TPPO 
system, applying the array of PAT tools to gain better process understanding.  
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2. MATERIALS AND METHODS 
2.1 Chemicals 
Crystallizations were carried out using MeCN as solvent and the resulting co-crystal 
complexes, 1:1 p-TSA-TPPO and 3:2 p-TSA-TPPO characterized using different solid-state 
techniques. Figure 1 shows the chemical structures of the starting materials (top) and crystal 
structures of the co-crystals (bottom). Acetonitrile (MeCN, Analytical Reagent Grade, 99.9 %) 
was obtained from Fisher Scientific, UK. p-Toluenesulfonamide (p-TSA, 99 %) and 
triphenylphosphine oxide (TPPO, 99 %) were obtained from Sigma-Aldrich, UK and used as 
received. The structure of 1:1 p-TSA-TPPO consists of cyclic centrosymmetric aggregates in 
which two molecules of p-TSA are linked to two molecules of TPPO via two point hydrogen 
bonds of the type :O----H–N(SO2Ph)–H----O: as shown in Figure 1, with a lone pair of 
electrons on the oxygen of TPPO. The 3:2 p-TSA-TPPO co-crystal is also made up of cyclic 
centrosymmetric aggregates, but with three molecules of p-TSA linked to two molecules of 
TPPO via a network of six linear hydrogen bonds of the type O----H–N(SO2Ph)–H----O, with 
no lone pair electrons on the oxygen of TPPO. 
 
Figure 1. Chemical structures of p-TSA and TPPO (top) and crystal structures of 1:1 and 
3:2 p-TSA-TPPO co-crystals (bottom). Adopted from Croker et al. [6]. 
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In this study, the ternary phase diagram of p-TSA/TPPO/MeCN at 20 
o
C, Figure 2, 
developed by Croker et al [13] was used as a guide for producing pure 1:1 and 3:2 p-TSA-
TPPO co-crystal forms (Regions 1 and 2), and mixtures (Region 3), albeit at different operating 
temperatures. The study aims to demonstrate that control over the co-crystallization process in 
batch and semi-batch crystallizer platforms is possible even under different operating 
conditions. 
 
Figure 2. Ternary phase diagram (axes in mass fraction) for the p-TSA/TPPO/MeCN at 
20 °C. (1) 3:2 co-crystal form stable; (2) 1:1 co-crystal form stable; (3) Mixtures of 1:1 and 
3:2 forms stable. Adopted from Croker et al. [13]. 
2.2 Solid State Characterization 
Powder X-ray diffraction (PXRD) studies were carried out using a Bruker D2 Phaser 
bench-top X-ray diffractometer with Cu Kα radiation source. A 3 mm anti-scatter slit was 
used with a programmable divergent slit of 1 mm. A 1.5
o
 Soller slit was employed and 
diffractograms were collected between 5 and 90
o
 2θ with a step size of 0.02o. In preparation 
for PXRD analysis, samples were mounted and spread evenly onto 12 mm discs. 
 
1 2 
3 
3:2 1:1 
   
p-TSA TPPO 
MeCN 
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A Thermo Scientific DXR
TM
 Raman Microscope equipped with 780 nm laser, Olympus 
TH4 200 optical component, and Linkam THMS600 heating/freezing stage was used for 
phase identification, polymorph characterization and image analysis. The full spectral range 
of the instrument (50 – 3500 cm-1) was captured with a single exposure of the 
charged-coupled-device (CCD). Samples for polymorph screening and imaging were 
mounted on glass slides and analysed using either, x4, x10 or x50 objective, resulting in spot 
sizes of 7.9, 3.8 and 1.3 µm respectively. Raman spectra were collected using the 50 µm slit 
and a laser setting of 15 mW. The number of scans and exposure time for each sample was 10 
x 10 s. The instrument settings led to estimated resolution of 4.7 – 8.7 cm-1. Data processing 
and analysis was carried out using Thermo Scientific OMNIC
TM
 Series Raman software and 
TQAnalyst
TM 
 version 8.0 software. 
Hot stage microscopy (HSM) studies were carried out using the Linkam THMS600 unit. 
The stage body fitted quick-to-fit gas port was connected to a LNP95 cooling pump to control 
the sample atmosphere using a dry nitrogen flow. Samples were loaded onto a 0.17 mm thick 
cover slip and placed on a highly polished pure silver heating element to ensure good heat 
transfer and sensitive temperature measurements. Samples were equilibrated at 100 
o
C, 
followed by controlled heating at a rate of 1 
o
C/min to 180 
o
C. Images were captured 
whenever phase changes were detected. 
A Thermo Scientific Nicolet™ iS™50 FT-IR benchtop spectrometer with a KBr beam 
splitter and DTGS ATR detector was used as a complementary tool to Raman spectroscopy 
for phase identification and polymorph characterization. The spectral range of the instrument 
was 400 – 4000 cm-1. Prior to analysis a background reading (5 scans averaged) was taken in 
air to eliminate interferences from CO2, H2O and other atmospheric gases. Samples were then 
mounted on the ATR iS50 window and fixed in place using a sample holder supplied with the 
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instrument. The instrument was set to absorbance mode and 10 scans were recorded and 
averaged over 10 seconds for each sample, leading to a spectral resolution of 4 cm
-1
. Data 
processing and analysis was carried out using Thermo Scientific OMNIC
TM
 Series FT-IR 
software and TQAnalyst
TM 
version 8.0 software. 
DSC analyses were carried out using a Thermal Advantage DSC Q20 fitted with a Thermal 
Advantage 90 cooling system, using nitrogen gas at a flow rate of 18 cm
3
/min. Each sample 
was equilibrated at 40 
o
C for 2 min followed by heating at a rate of 5 
o
C/min to 250 
o
C. Data 
were collected and processed using the Instruments-Waters LLC Advantage Qseries version 
5.4.0 software package supplied with the instrument.  
Scanning Electron Microscopy (SEM) studies were carried out using a Carl Zeiss 1530 VP 
high resolution field emission gun scanning electron microscope (FEGSEM). Samples were 
prepared for SEM analysis using a bench-top Quorum Q150T ES gold sputter coater/carbon 
evaporator coating system with turbo-molecular pump. The system was used to coat each 
sample with a thin film of gold-palladium prior to analysis. 
HPLC analyses were performed using a Hewlett Packard HP1100 Series chromatograph 
with a DAD.G1315A diode array detector using a Waters Spherisorb C8 Column (80Å, 
5 µm, 4.6 mm × 250 mm) eluting with MeCN:H2O (80:20) at 1 mL/min and UV detection at 
254 nm. 
2.2  Batch Co-Crystallization Study 
Small scale batch co-crystallization studies (1 – 50 mL) on the p-TSA-TPPO system have 
previous been reported [6], [13], [29]. The co-crystallization experiments were carried out in 
a 500 mL jacketed glass vessel fitted with an overhead PTFE pitch blade stirrer. The jacket 
was connected to a Thermofluid bath (Huber ministat 230) for temperature control. 
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Temperature profiles were implemented and data recorded using CryPRINS software 
(version 2.0). A RXN1 Raman spectrometer from Kaiser Optical Inc. with 785 nm laser 
source and immersion probe was used for in situ real-time monitoring of the co-crystal forms 
of p-TSA-TPPO. FBRM
®
 D600 and PVM
®
 instruments from Mettler Toledo were used for 
nucleation and dissolution detection, and to tracking the evolution of crystal properties (size 
shape and distribution). An ATR-UV/vis spectrometer fitted with Helma 661.820-UV 
immersion probe or Thermofisher FTIR spectrometer fitted with artphotonics ATR Silicium 
SN 210 immersion probe was used to monitor changes in the solution phase. A schematic 
representation of the experimental set-up used is shown in Figure 3.  
 
Figure 3. Schematic of batch crystallizer used for the cooling co-crystallization 
experiments.  
For each experimental run, the required amount of p-TSA, TPPO and MeCN were added to 
the reactor and heated to 30, 60 or 70 
o
C to dissolve the solids (depending on the initial 
loading of starting materials) at a rate of 1 
o
C/min. The vessel was held for 15 min to allow 
complete dissolution of the materials, followed by cooling at a rate of -1.0 
o
C/min to a final 
temperature of either 20 or 5 
o
C, and holding for 1 hour (experiments 1 – 4). For experiments 
5 – 9 ramped temperature profiles were implemented, the heating/cooling rate regime was 0.2 
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/ - 0.2 
o
C/min. The impeller speed for all experiments was set to 400 rpm, which corresponds 
to an approximate power per unit volume of 0.075 kW/m
3
. Table 1 gives a summary of the 
experimental conditions for each run. The material from each experimental run was isolated 
at the end of the batch time by vacuum filtration. The wet solid collected was then dried 
overnight at 40 
o
C. 
Table 1. Summary of experimental conditions employed during the batch crystallization of 
p-TSA-TPPO co-crystals. 
Exp 
No. 
p-TSA 
(g/g 
MeCN) 
TPPO 
(g/g 
MeCN) 
Temperature  
(
o
C) 
Heating / 
Cooling Rates 
(
o
C/min) 
Component Mass Fractions 
(M) 
Region of 
Phase 
Diagram at 
20 
o
C 
Initial Final p-TSA TPPO MeCN 
1 0.1147 0.1532 60 20 / 5
*
 1.0 / -1.0 0.09 0.12 0.79 2 (1:1 form) 
2 0.2634 0.1247 60 20 / 5
*
 1.0 / -1.0 0.19 0.09 0.72 1 (3:2 form) 
3 0.5776 0.4202 70 5 1.0 / -1.0 0.29 0.21 0.50 1 (3:2 form) 
4 0.3793 0.6193 70 5 1.0 / -1.0 0.19 0.31 0.50 2 (1:1 form) 
5 0.0706 0.1059 30 5 0.2 / -0.2 0.06 0.09 0.85 2 (1:1 form) 
(6) 0.1728 0.0617 30 5 0.2 / -0.2 0.14 0.05 0.81 1 (3:2 form) 
(7) 0.1049 0.0968 30 20 0.2 / -0.2 0.09 0.08 0.83 3 (Mixture) 
8 0.1084 0.0964 30 20 0.2 / -0.2 0.09 0.08 0.83 3 (Mixture) 
9 0.0833 0.1071 30 5 0.2 / -0.2 0.07 0.09 0.84 2 (1:1 form) 
*Cooled to 20 oC and held for 60 min, followed by cooling to 5 oC and holding for 60 min; ( ) Temperature cycles 
implemented. 
2.2 Semi-Batch Co-Crystallization Study 
A series of semi-batch development experiments were performed to determine the most 
suitable conditions for the selective crystallization of the 1:1 and 3:2 stoichiometric co-crystal 
forms of the p-TSA-TPPO co-crystals system. The combination of p-TSA/TPPO/MeCN was 
varied on a mass fraction basis by changing the flow rate of each co-former. All experiments 
were carried out using the experimental set-up described in section 2.1 (Figure 3). The 
required amount of p-TSA and TPPO were dissolved in separate vessels to generate 
undersaturated solutions according to Table 2. Solutions were prepared by heating 
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suspensions of p-TSA and TPPO in MeCN to 30 
o
C and then holding for 15 min to allow 
complete dissolution of the materials. The resulting solutions were then cooled to 25 
o
C and 
pumped separately to the 500 mL crystallizer vessel kept at 20 
o
C. Figure 4 shows a flow 
diagram of the experimental set-up used. 
 
Figure 4. Flow diagram showing the configuration of the semi-batch experimental set-up 
used during the co-crystallization studies. 
Calibrated and pre-programmed Masteflex
®
 pumps fitted with 3.1 mm ID platinum cured 
tubing were used to pump p-TSA-MeCN and TPPO-MeCN solutions to the batch crystallizer. 
The flow rates of p-TSA and TPPO solutions were varied from 15 to 32.7 g/min and 20 to 
37.7 g/min respectively. The targeted combined flow rate of the two streams was 52.7 g/min 
for each experimental run. Pumps were programmed to operate for 6.71 min, leading to the 
delivery of approximately 493 mL of combined p-TSA-TPPO-MeCN solution to the 
crystallizer, which was initially empty. A holding period of approximately 60 min was 
implemented after the crystallizer was filled. For all experiments, the impeller speed of the 
crystallizer was set to 400 rpm. Table 2 provides a summary of the conditions employed 
during each experimental run. 
13 
 
Table 2. Summary of experimental conditions employed during the semi-batch 
crystallization of p-TSA-TPPO co-crystals. 
Exp 
No. 
p-TSA 
(g/g 
MeCN) 
TPPO 
(g/g 
MeCN) 
Solution Flow Rates  
(g/min) 
Mass Fractions (M) 
in Crystallizer 
Region of 
Phase 
Diagram at 
20 
o
C 
p-TSA soln. TPPO soln. p-TSA TPPO MeCN 
10 0.2987 0.1482 28 24.7 0.12 0.09 0.79 1 (3:2 form) 
11 0.2987 0.1482 32.7 20.0 0.14 0.05 0.81 1 (3:2 form) 
12 0.2987 0.1482 20.0 32.7 0.09 0.08 0.83 3 (mixture) 
13 0.2987 0.1482 15.0 37.7 0.06 0.09 0.85 2 (1:1 form) 
14 0.4625 0.2016 20.0 32.7 0.12 0.12 0.76 2 (1:1 form) 
15 0.2987 0.1482 23.4 29.3 0.10 0.08 0.83 3 (mixture) 
16 0.2987 0.1482 17.7 35 0.08 0.08 0.84 3 (mixture) 
17 0.2987 0.1482 27.5 25.2 0.11 0.07 0.82 1 (3:2 form) 
3. RESULTS AND DISCUSSION 
The ternary phase diagram for p-TSA/TPPO/MeCN was constructed and fully explored by 
Croker et al. [13] using small scale experiments. In the current work, the mass fractions of 
p-TSA/TPPO/MeCN were varied according to the ternary phase diagram shown in Figure 2. 
The phase diagram was used as a guide to selecting conditions that favor the formation of either 
the 3:2 or 1:1 co-crystal forms, as well as conditions that favor the formation of mixtures of the 
two forms. 
3.1 Solid State and Solution Phase Characterizations 
The raw materials p-TSA, TPPO and MeCN were characterized both in the solid phase 
(using PXRD, off-line Raman and ATR-FTIR spectroscopy, HPLC, DSC and SEM) and 
solution phase (using in situ Raman spectroscopy). The solid and liquid phase 
characterizations were later compared to samples acquired from each of the batch 
experimental runs. In house reference samples for the 1:1 and 3:2 p-TSA-TPPO co-crystal 
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forms were prepared according to the procedures of Croker et al. [13], [29], solid state 
characterizations were carried out using the techniques described earlier.  
PXRD, Raman Microscopy, ATR-FTIR and DSC Analyses: Figure 5 (a) – (d) shows the 
patterns obtained from PXRD (a), Raman (b), ATR-FTIR (c), and DSC (d) solid state 
characterizations of the starting materials and co-crystal reference material, respectively. For 
each material analysed, the patterns show distinctive features that were exploited to identify 
subsequent samples collected from different experimental runs during the study. 
 
Figure 5. Solid state characterization results for p-TSA, TPPO and 1:1 co-crystal reference, 
3:2 reference, 1:1 co-crystal simulated and 3:2 co-crystal simulated, showing: (a) PXRD 
patterns; (b) Raman spectra; (c) ATR-FTIR spectra; and (d) DSC patterns. 
Clear differences are observed between the co-crystal forms and their respective starting 
materials and physical mixture. For example, The PXRD patterns show distinctive broad (1:1 
p-TSA-TPPO) and sharp (3:2 p-TSA-TPPO) peaks in the 2-Theta (
o
) positions 7 – 10 and 17 
(a) (b) 
(c) (d) 
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– 22. The Raman spectra show differences in peak width and position in the regions 3180 – 
2855, 1150 – 890, and 780 – 480 cm-1. In terms of the ATR-FTIR signal, 1:1 and 3:2 p-TSA-
TPPO both show distinctive broad peaks in the region 3400 – 3100 cm-1. Distinctive 
differences between the two forms are also observed in the fingerprint region from 1500 to 
400 cm
-1
. The DSC patterns also show the clear difference between the melt of the two 
co-crystals, their parent compounds and physical mixture. The melts for the different 
crystalline phases are observed at approximately 140 
o
C (1:1 p-TSA-TPPO), 144 
o
C (3:2 
p-TSA-TPPO), 139 
o
C (p-TSA) and 159 
o
C (TPPO). Interestingly, the physical mixture of 
p-TSA and TPPO shows a very broad endotherm from approximately 121 – 140 oC. It is 
unclear why there is such a significant shift in the endotherm for the physical mixture of the 
two compounds. DSC scans from replicate runs showed a similar profile, which suggests that 
heating the two substances together leads either to the lowering of both of their melting 
points or the formation of different crystalline phase, which has a lower melting point. 
However, these hypotheses require further investigations, which are beyond the scope of the 
current study. 
HPLC Analyses: Samples from each of the experimental runs performed during this study 
were characterized using the solid state techniques described above, and the resulting patterns 
compared to the raw material and reference patterns, as shown in Figure 5. The purity and 
stoichiometric composition of the 1:1 and 3:2 p-TSA-TPPO co-crystal forms was confirmed 
by HPLC, applying a univariate calibration model developed by preparing different mass 
fractions of the starting materials (p-TSA and TPPO) in MeCN and finding the ratio between 
the areas of the resolved peaks of both components. Figure 6 shows the calibration curve used 
to determine the relative amount of p TSA and TPPO in samples obtained from each 
experimental run. The regions corresponding to 1:1 and 3:2 p-TSA-TPPO (i.e. based on % 
Mass TPPO) are indicated by dashed lines. 
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Figure 6. Univariate HPLC calibration model used to determining the purity and 
stoichiometry of 1:1 and 3:2 p-TSA-TPPO co-crystal forms.  
HSM Analyses: Hot stage microscopy studies we carried out on co-crystal samples 
obtained from selected experimental runs. Figure 7 (a) and (b) show the images captured 
from 100 
o
C until 148 
o
C (left) and DSC scans (right) for the melting of 3:2 and 1:1 p-TSA-
TPPO. For the hot stage microscopy study, melting was observed in the temperature ranges 
141 – 148 oC, and 139 – 143 oC for 3:2 p-TSA-TPPO, and 1:1 p-TSA-TPPO, respectively, 
showing good agreement with DSC which gave melting points of 143.7 
o
C and 139.9 
o
C for 
the respective co-crystal forms. The additional endothermic event at 128.2 
o
C observed in the 
3:2 co-crystal profile is most likely residual starting material since this peak seems to 
correspond to the melt of physical mixture of p-TSA and TPPO as shown in Figure 5 (d). All 
analytical tools (off-line and on-line) used in the study indicated pure 3:2 p-TSA-TPPO 
including HPLC. 
1:1 
3:2 
17 
 
 
Figure 7. Hot stage microscopy images (left), (a) 1:1 p-TSA-TPPO and (b) 3:2 p TSA-
TPPO; and respective DSC scans (right) for each sample. 
SEM Analyses: Figure 8 (a) – (d) shows SEM micrographs (x60 magnification) of smaples 
with different co-crystal compositions. The distinct morphology of the 1:1 and 3:2 p-TSA-
TPPO is evident from the SEM micrographs. In particular, Figure 8, images (e) (x300) and (f) 
(x400) show clearly the rhombic and rod shapes of the 1:1 (e) and 3:2 (f) crystalline forms of 
p-TSA-TPPO, respectively. Figure 8 (c) and (d) obtained from two different experimental 
runs show a clear distinction in crystal size, which is attributed to a difference in the mass 
fraction composition of materials in the batch crystallizer (which is related to the 
supersaturation). This leads to different crystal sizes, which suggests that the mass fraction 
(b) 
100 oC 139 oC 
141 oC 143 oC 
139.9 
o
C 
(a) 
100 
o
C 141 
o
C 
146 
o
C 148 
o
C 
143.7 
o
C 
128.2 
o
C 
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composition of materials in the crystalliser can be adjusted to control the mean size and CSD 
of the final product. 
 
Figure 8. SEM micrographs of (a) 1:1 p-TSA-TPPO (x60); (b) mixture of 1:1 and 3:2 
p-TSA-TPPO (x60); (c) and (d) 3:2 p-TSA-TPPO (x60); and (e) 1:1 p-TSA-TPPO (x300) and 
(f) 3:2 p TSA TPPO (x400) crystals.  
Using the equilibrium solubility [13] at the crystalliser operating temperature (20 
o
C), the 
supersaturation with respect to 1:1 p-TSA-TPPO for these two experiments works out to 2.94 
(c) and 1.77 (d), respectively. It appears that the growth of the crystals is extremely fast and is 
favoured at low supersaturation (d) compared to higher supersaturation (c), which is 
expected. However, the supersaturation of the former is still quite high, which suggest that 
the 3:2 co-crystal phase is extremely fast growing as crystals greater than 1 mm size were 
observed. 
3.2 In situ Process Monitoring and Characterization 
Real-time in process characterizations were carried out applying in situ Raman and 
ATR-FTIR spectroscopy to clear solutions and suspensions of 1:1 and 3:2 p-TSA-TPPO, 
respectively. Figure 9 shows the regions selected from Raman spectroscopy for identification 
(c) 
(d) 
(b) (a) 
(e) (f) 
x60                       1mm 
x60                        1mm x300                     300µm x400                     200µm 
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of the different phases. Results from each of the co crystallization runs were routinely 
correlated with HPLC measurements on samples taken at different intervals in order to 
confirm the identity of the solid forms present. Where necessary, other off-line measurement 
techniques as described earlier in sections 2.2 and 3.1 were also employed to validate the 
results from the in situ process measurements and HPLC, for example, in cases where a 
mixture of different crystalline forms were suspected. This study highlights the 
complementarity of off-line and in situ process measurements. Furthermore the application of 
both methods provides a robust analysis of the co-crystallization process as well as valuable 
information for process scale-up. 
 
Figure 9. Regions of in situ Raman spectra used to differentiate between solution and solid 
phases of the p-TSA/TPPO/MeCN system.  
In Figure 9 the Raman spectral bands in the regions 200 – 350, 600 – 700, 1050 – 1250 and 
1550 – 1610 cm-1 correspond, respectively, to modes of aromatic ring wagging (233 – 
262 cm
-1
), C-N bending (289 – 304 cm-1), ring C-H and ring out-of-plane bending (710 – 
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770 cm
-1
), N -H bending and ring C-H bending (784 – 825 cm-1), C-C ring stretching and C-S 
stretching  (1083 – 1110 cm-1), P=O symmetric and asymmetric stretching (1130 – 1200 cm-
1
) and aromatic ring vibrations (1560 – 1620 cm-1) [31].  
It has been shown so far that off-line solid-state and in situ characterization techniques can 
be applied effectively to distinguish between the different crystalline forms of p-TSA and 
TPPO, including their stoichiometric co-crystal forms. This information can be applied not 
only to distinguish between crystalline forms, but also to inform the development of effective 
crystallization control strategies in batch, semi-match and periodic flow crystallizers. 
3.3 Batch Co-Crystallization Monitoring and Control  
The batch cooling co-crystallization of p-TSA and TPPO to give stoichiometric 1:1 and 
3:2 p-TSA-TPPO co-crystal forms was monitored by applying an integrated PAT array 
(Figure 3) to extract information pertaining to the stability of each co-crystal form under 
different operating conditions. A further aim was to optimize the batch process for the 
selective crystallization of each co-crystal form, achieved by tuning either the starting 
composition of p-TSA/TPPO/MeCN or the crystallization temperature profile. Figure 10 (a) 
and (b) shows the process time diagrams obtained from monitoring the crystallization of 
1:1 and 3:2 p-TSA-TPPO during experiment 1 and 2 (Table 1) respectively using FBRM, 
ATR-UV/vis and ATR-FTIR spectroscopy. Also shown are the microscope images of the 
crystalline products. The 1:1 form of p-TSA-TPPO show a distinct rhombic morphology, 
while the 3:2 form exhibits a rod-like morphology. The infrared spectra of both co-crystal 
forms show distinct differences in the regions associated with C-H stretching (2900 – 3000 
cm
-1
) and N-H stretching (3000 – 3400 cm-1) vibration frequencies [31] (Figure 10, bottom 
right). Off-line Raman, XRD, DSC and HPLC also confirmed the purity of each co-crystal 
form. 
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The time diagrams (Figure 10 (a) and (b)) were annotated to indicate where important 
events occurred during each crystallization run. The signals from each PAT show good 
agreement with respect to the detection of nucleation, although the ATR-UV/vis and ATR-
FTIR signals are affected by temperature. Nucleation of 1:1 p-TSA-TPPO (Figure 10 (a) – 
experiment 1) is not observed until cooling toward 5 
o
C (at approximately 6.5 
o
C). On the 
other hand, nucleation of 3:2 p-TSA-TPPO (Figure 10 (b) – experiment 2) occurs at 
approximately 21 
o
C. This was due to the difference in mass fraction composition of p-
TSA/TPPO/MeCN, that is, 0.09/0.12/0.79 (experiment 1 - 1:1 p-TSA-TPPO) and 
0.19/0.09/0.72 (experiment 2 - 3:2 p-TSA-TPPO). The corresponding supersaturation (S) 
values for the experiments 1 and 2 were 2.29 and 2.69, respectively (i.e. based on solubility 
of 1:1 p-TSA-TPPO at 20 
o
C). The cooling rate was held constant for experiment 1 and 2, 
respectively (see Table 1) and the overall temperature profile was the same. These 
experiments were found to be reproducible, in terms of the co-crystal outcome. In addition to 
detecting signal from the solution phase, the ATR-FTIR probe was also able to detect the 
solid phase signal consistently, albeit at the lower limit of the instrument (650 cm
-1
) when 
1:1 p-TSA-TPPO nucleated. This is not entirly surprising since it is well known that ATR-
FTIR can be affected by particle scattering [32], [33], and to a much greater extent than 
ATR-UV/vis, which shows much less sensitivity [34]. However, the ATR-FTIR signal 
observed for the 3:2 co -crystal experiment (Figure 10 (b) – experiment 2) cannot be properly 
interpreted, as it was found to change in almost exactly the same way as the temperature 
profile, that is, except for a sudden spike in the 650 cm
-1
 peak signal at approximately 110 
min. The spike was consistent with a sudden increase in FBRM counts/s and a simultaneous 
drop in ATR-UV/vis absorbance, with confirmation of the presence of crystals obtained via 
real-time PVM measurements. The change in behavior of the 650 cm
-1
 peak signal is 
attributed to material sticking on the probe window leading to observed change in the signal 
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behavior. Furthermore, peaks that are close to the limits of the ATR-FTIR range (for the 
study the instrument had a range 650 – 2800 cm-1) are often not consistent due to small signal 
to noise ratio, and therefore their reliability for interpretation of process behavior is strongly 
cautioned.  
  
Figure 10. Schematic showing the process time diagrams with temperature, ATR-UV/vis, 
ATR-FTIR and FBRM signals for the crystallization of 1:1 (a) and 3:2 (b) p-TSA-TPPO 
along with microscope images (top right) and off-line ATR-FTIR spectra (bottom right) of 
samples collected at the end of both processes. 
The mass fraction of MeCN was fixed to 0.50 for experiments 3 and 4 (Table 1) and the 
amount of p-TSA and TPPO varied according to the recipe by Croker et al. [13] for obatining 
pure 3:2 and 1:1 p-TSA-TPPO respectively by cooling crystallizations at 50 mL scale. For 
the respective experimental runs (3 and 4), pure 3:2 and 1:1 p-TSA-TPPO were obtained, as 
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confirmed by off-line analysis (HPLC, Raman microscopy, off-line ATR-FTIR, SEM and 
DSC). However, due to the high solubility of p-TSA and TPPO in MeCN, it seems 
impractical to consider scale-up of the co-crystallization process applying the conditions used 
for experimental runs 3 and 4, since the high viscosity of the slurry at these high 
concentrations leads to poor mixing and suspension of the crystals. Furthermore, speciality 
agro chemicals are often highly toxic and expensive, plus the bulk storage of materials could 
pose health and environmental risks [1]. Therefore, the co-crystallization was investigated at 
much lower concentrations of p-TSA and TPPO in MeCN (see Table 1), exploiting the upper 
most regions (toward MeCN) of the terniary phase diagram. Table 3 provides a summary of 
the outcomes in terms of co-cystal form obatined, based on-line (in situ Raman) and off-line 
(Raman microscopy, off-line ATR-FTIR, SEM and DSC) analyses. 
Table 3. Summary of co-crystallization outcomes for the experiments 1 – 10, co-crystal 
form determined by on-line and off-line measurements. 
Exp 
No. 
p-TSA 
(g/g 
MeCN) 
TPPO 
(g/g 
MeCN) 
Component Mass 
 Fractions (M) HPLC Ratio 
p-TSA/TPPO 
p-TSA-TPPO 
Co-Crystal 
Form 
Region of 
Phase 
Diagram at 
20 
o
C 
p-TSA TPPO MeCN 
1 0.1147 0.1532 0.09 0.12 0.79 1.034 1:1 2 (1:1 form) 
2 0.2634 0.1247 0.19 0.09 0.72 1.486 3:2 1 (3:2 form) 
3 0.5776 0.4202 0.29 0.21 0.50 1.470 3:2 1 (3:2 form) 
4 0.3793 0.6193 0.19 0.31 0.50 1.002 1:1 2 (1:1 form) 
5 0.0706 0.1059 0.06 0.09 0.85 1.000 1:1 2 (1:1 form) 
(6) 0.1728 0.0617 0.14 0.05 0.81 1.477 => 1.002 3:2 => 1:1 1 (3:2 form) 
(7) 0.1049 0.0968 0.09 0.08 0.83 1.463 => 0.998 3:2 => 1:1 3 (Mixture) 
8 0.1084 0.0964 0.09 0.08 0.83 1.006 1:1 3 (Mixture) 
9 0.0833 0.1071 0.07 0.09 0.84 1.002 1:1 2 (1:1 form) 
( ) Temperature cycles implemented to convert from 3:2 to 1:1 p-TSA-TPPO. => Direction of transformation on 
implementation of temperature cycles. 
The expected results in terms of co-crystal form were obtained for each composition of 
p-TSA/TPPO/MeCN investigated, with the exception of experiments (7) and 8. For these 
identical experimental runs, 3:2 and 1:1 p-TSA-TPPO respectively were initially obtained. 
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The lilkely reason for this is the operation of the process in a region where both 1:1 and 
3:2 p-TSA-TPPO were most likely to nucleate (i.e., region 3 of Figure 2 as a guide) and 
co-exist as a mixture. These two identical experiments (note that temperature cycling was 
applied to (7) later) were expected to yield a mixture of 1:1 and 3:2 p TSA-TPPO. Instead, 
3:2 p-TSA-TPPO and 1:1 p TSA-TPPO were obtained from experiment (7) and 8, 
respectively. The initial outcomes perhaps highlights variability issues that can arise in a 
batch process.. It must be noted that the experimental conditions employed for runs (7) and 8 
reflect the dynamics of the crystallization kinetics of the co-crystal system. The ternary phase 
diagram on the other hand reflects the thermodynamic stability at a fixed temperature of 20 
o
C. If the crystallizer was held for a long period (e.g. 24 hrs.) at 20 
o
C, then perhaps a mixture 
of the two co-crystals would have prevailed in experiments (7) and 8. Temperature cycling 
was later applied to the initial product from experiment (7) and this led to a transformation 
from 3:2 to 1:1 p-TSA-TPPO. As demonstrated here, temperature cycling can be applied as 
an effect control strategies to direct the co-crystallisation toward a desided outcome and 
within a short time period. Temperature cycling approach using active polymorphic feedback 
control based on in situ Raman spectroscopy is a promising method recently explored by 
Simone et al. [35] to eleminate the undesired polymorph (form II) of orthoaminobenzoic acid 
(OABA) and then grow the desired form I. In this study, a simple simple temperature cycling 
approach was employed to eleminate the undesired 3:2 stoichiometric form of p-TSA-TPPO 
and grow the desired 1:1 form from experiments (6) and (7). The 1:1 co-crystal form is 
desired since the 3:2 form exhibits incongruent dissolution behaviour in MeCN [13], [30]. 
These experiments also shed light on the stability and by extension the thermodynamics of 
the crystallisation of 1:1 and 3:2 p-TSA-TPPO, respectively. The temperature cycles in 
experiments (6) and (7) were implemented based on the in situ Raman signal of peaks 
associated with the 3:2 and 1:1 p-TSA-TPPO co-crystal forms, respectively.   
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Figure 11 shows the process time diagram for the crystallization of 3:2 p-TSA TPPO 
during experiment (7). The mixture was heated up and subjected to a complex temperature 
profile with ramped heating and cooling cycles (Figure 11). The same temperature profile 
was used for experiments (6). The final product obtained from the experiment (6) and (7) was 
pure 1:1 p-TSA-TPPO, as confirmed by on-line Raman spectroscopy and the off-line solid 
state characterization methods described earlier.  
 
1 = Sample 1 at 57 min. 5 = Sample 3 at 272 min. 9 = Nucleation event. 
2 = Sample 2 at 109 min. 6 = Signal loss/fluorescence 10 = Sample 5 at 1137 min.** 
3 = Nucleation event 7 = Nucleation event **growth/agglomeration / 
   settling observed. 4 = Dissolution event 8 = Sample 4 at 177 min. 
Figure 11. Process time diagram for experiment (7) showing the changes in FBRM count/s 
and in situ Raman 2nd derivative signals (top), temperature profile implemented (bottom left) 
and microscope images of samples (bottom right). 
Figure 11 also shows the point where the first sample was taken from the process (arrow 1; 
image S1). The sample taken was confirmed to be pure 3:2 p-TSA-TPPO by both on-line and 
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off-line measurements. Following on from that point is the dissloution of 3:2 p-TSA-TPPO 
(arrow 2, image S2) ), which is marked by a decrease in the FBRM counts/s and the 2
nd
 
derivative of Raman peak signal at 304 cm
-1
. Subsequent to this event, nucleation of 
1:1 p-TSA-TPPO occurs (arrow 3), marked by an sudden increase in FBRM counts/s and the 
2
nd
 derivative of Raman peak signal 1145 cm
-1
. This is followed by slight dissolution as the 
temperature heating cycle continues (arrow 4). At approximately 270 min there is a rapid 
increase in the FBRM counts/s and simultaneous increase in the 2
nd
 derivative 1145 cm
-1
 
peak signal (arrow 5; image S3) due to implementation of a temperature cooling cycle. This 
is attributed to secondary nucleation of 1:1 p-TSA-TPPO as the amount of 3:2 p-TSA-TPPO 
diminishes.  
The relative solubility of each co-crystal phases plays an important role in the conversion 
between forms. The 3:2 co-crystal is known to undergo incongruent dissolution, whereby 
there is a transformation step involving the formation and subsequent dissolution of 1:1 
p-TSA-TPO [36]. The temperature cooling step implemented from approximately 334 to 
490 min (cooling rate of -0.2 
o
C/min) led to further secondary nucleation of 1-1 pTSA-TPPO 
(arrow 7). The microscpe image of sample 3, Figure 11 (image S3), shows there is a mixture 
of 3:2 and 1:1 p-TSA-TPPO. The presence of a mixture was also confirmed by off-line solid 
state characterizations and HPLC analysis. Following this, a temperature heating step was 
implemented (heating rate of 0.2 
o
C/min) to dissolve 3:2 p-TSA-TPPO (arrow 8; image S3). 
This was then followed by another cooling step to nucleate and grow 1:1 p-TSA-TPPO 
(arrow 10; image S4). The final sample collected at the end of the batch (image S5) was 
found to be pure 1:1 p-TSA-TPPO.  
The work presented here is a proof of concept study whereby the mass faction composition 
and temperature cycling are applied to control the co-crystallization process in order to 
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obtained the desired stoichiometric form of the p-TSA-TPPO co-crystal system. It has been 
demonstrated that the co-crystal form can be controlled by manipulating the composition of 
p-TSA, TPPO and MeCN, as previously demonstrated by Croker et al. [13], [30] in small 
scale studies. The stoichiometric purity of the final co-crystal was assured by implementation 
of a complex array of on-line and off-line monitoring and characterization techniques. Also 
demonstrated is the application of a complex temperature profile having several heating and 
cooling cycles to influence the outcome of the co-crystallisation when the undesired form is 
initially obtained. The process was also characterized using a combination of on-line and 
off-line PAT tools. Attempts to convert from 1:1 to 3:2 p-TSA-TPPO were unsuccessful, 
however, studies are ongoing to investigate if this is possible using the same scale of 
equipment used in this study. 
3.4 Semi-Batch Co-Crystallization Monitoring and Control 
The semi-batch co-crystallization of p-TSA with TPPO was explored under flow conditions 
whereby a fixed concentration of the two starting materials dissolved in MeCN are pumped 
separately, then combined and mixed in a batch crystallizer (see Figure 4). In this study the 
flow rates of the two components were adjusted to crystallize the desired stoichiometric form 
of the p-TSA-TPPO co-crystal system. This operating strategy offers a  promising alternative 
to batch, and could potential lend itself to further development into a continuous 
co-crystallization operation. Table 4 provides a summary of the co-crystallization outcomes 
for each of the semi-batch experimental runs. 
Figure 12 (a) and (b) shows the process time diagrams with temperature profile and on-line 
PAT signals from FBRM (solid phase), ATR-UV/vis (solution phase), ATR-FTIR (solution 
phase) and Raman (co-crystal form and solution phase monitoring) for experiment 10. The 
co-crystal form obtained from this experiment was pure 3:2 p-TSA-TPPO as confirmed by 
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both on-line (Raman MR immersion probe) and off-line (HPLC, PXRD, Raman microscope 
and ATR-FTIR) measurements. Experiments 11 – 17 (Table 4) were carried out under similar 
process conditions to experiment 10, meaning the process temperature (varying from 25 
o
C 
=> 20 
o
C) and concentrations of p-TSA (0.2987 g/g MeCN) and TPPO (0.1492 g/g MeCN) in 
the feed vessels were exactly the same. The main difference between these runs is the mass 
flow rate of p-TSA and TPPO from the feed vessels (Figure 4) to the crystallizer. The results 
show that by changing the mass flow rate of either p-TSA or TPPO, one can change the mass 
fraction composition of materials in the crystallizer and thereby control the co-crystallization 
outcome. When the flow rate is adjusted so that the mass fractions of p-TSA and TPPO are 
similar, the resulting mixture falls into region 3 of the ternary phase diagram and hence two 
co-crystal forms were obtained, for example, as observed from experiments 12 and 16 
(Table 4). 
Table 4. Summary of co-crystallization outcomes for the experiments 10 – 17, co-crystal 
form determined by on-line and off-line measurements. 
Exp 
No. 
Solution Flow 
Rates  
(g/min) 
Mass Fractions (M) 
in Crystallizer HPLC Ratio 
p-TSA/TPPO 
p-TSA-TPPO 
Co-Crystal 
Form 
Region of 
Phase 
Diagram at 
20 
o
C 
p-TSA 
soln. 
TPPO 
soln. 
p-TSA TPPO MeCN 
10 28.0 24.7 0.12 0.09 0.79 1.479 3:2 1 (3:2 form) 
11 32.7 20.0 0.14 0.05 0.81 1.522 3:2 1 (3:2 form) 
12 20.0 32.7 0.09 0.08 0.83 1.313 1:1 + 3:2 3 (mixture) 
13 15.0 37.7 0.06 0.09 0.85 1.002 1:1 2 (1:1 form) 
14 20.0 32.7 0.12 0.12 0.76 1.021 1:1 2 (1:1 form) 
15 23.4 29.3 0.10 0.08 0.83 1.475 3:2 3 (mixture) 
16 17.7 35 0.08 0.08 0.84 1.333 1:1 + 3:2 3 (mixture) 
17 27.5 25.2 0.11 0.07 0.82 1.475 3:2 1 (3:2 form) 
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Indeed, the semi-batch co-crystallization experiments were more consistent in terms of 
co-crystallization outcomes when compared to the batch runs described earlier (Section 3.2). 
Moreover, slight changes in the mass flow rate of one or both co-formers can alter the 
co-crystallization outcome favoring either 1:1 or 3:2 p-TSA-TPPO or a mixture. However, 
these changes can be avoided if the flow rates are controlled appropriately. 
 
Figure 12. Process time diagrams of experiment 10 showing the temperature profile, (a) 
FBRM total particle counts/s (solid phase monitoring) and the change in absorbance and peak 
intensity readings from ATR-UV/vis and ATR-FTIR probes used to monitor the liquid phase; 
and (b) changes in the 2
nd
 derivative of Raman peaks at 1145 and 304 cm
-1
, associated with 
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1:1 and 3:2 p-TSA-TPPO, respectively, and the liquid phase. Arrows show respectively, 
nucleation (FBRM counts/s) (1), decreasing solute in solution phase (2), crystal growth (3), 
increasing 3:2 p-TSA-TPPO peak (4), 1:1 p-TSA-TPPO peak (5), and change in solution 
phase (6). 
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3.5 Principal Component Analysis on in situ Raman Spectra 
Principal component analysis (PCA) is often used in chemometrics to extract the dominant 
patterns from chemical data. The result is a complementary set of scores and loadings that 
can be used to visualize trends in the data [37]. PCA analysis was performed on the Raman 
spectra obtained when pure 1:1 and 3:2 p-TSA-TPPO and mixture of the two co-crystals 
forms nucleated; a total of 390 spectra obtained from the batch and semi-batch experiments 
described earlier. Figure 13 shows the scores plot of principal components 1 and 2 obtained 
from the analysis. It shows there are three clusters of data corresponding to each of the three 
experimental runs. Analysis of the PCA scores plot allows for the identification of the co-
crystal form obtained from each of the experimental runs. PC1 and PC2 combined represent 
93.2 % of the spectral variance. The three distinct clusters indicate that a different co-crystal 
form or a mixture of forms was obtained from each experimental run. Clusters 1, 2 and 3 
represent experiments 10, 12 and 13 respectively, and the co-crystal forms were 3:2, mixture 
of 1:1 and 3:2, and 1:1 p-TSA-TPPO respectively. Arrows show the direction of increasing 
amount of solids as the crystallization progresses. PCA is an additional tool that was used to 
monitor and characterize the co-crystallization process, providing valuable information 
pertaining to the crystalline form that nucleates and grows.  
 
Figure 13. PCA scores plot of Raman spectra from experimental runs 10 (cluster 1), 12 
(cluster 2) and 13 (cluster 3). Arrows show the direction of increasing amounts of solids as 
the crystallizations progress.  
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4. CONCLUSIONS 
In this study, the cooling co-crystallization of p-TSA with TPPO to form either the 1:1 or 3:2 
p-TSA-TPPO stoichiometric co-crystal from MeCN was demonstrated in laboratory scale 
500 mL batch and semi-batch crystallizers. Monitoring and control of the selective 
co-crystallization of 1:1 and 3:2 p-TSA-TPPO was achieved using an integrated array of PAT 
tools complemented by off-line solid state characterization techniques. These technologies 
allowed gave a better understanding of the co-crystallization process. Three different regions 
of the p-TSA/TPPO/MeCN ternary phase diagram corresponding to the formation of the pure 
co-crystals as well as mixtures of both forms were explored by changing the mass fraction 
compositions of p-TSA/TPPO/MeCN in the crystallizers.  
In the batch study, as expected the pure 1:1 and 3:2 co-crystal forms were successfully 
isolated when the process was operated well within the respective stable regions extrapolated 
from the ternary diagram at 20 
o
C. However, batch-to-batch variability issues were 
occasionally encountered when the process was operated in the mixture region. It was 
demonstrated that if temperature cycling is implemented with the aid of in situ Raman 
spectroscopy measurements and off-line solid-state characterization methods, then the 
crystallization can be controlled and directed towards the desired outcome, that is, to obtain 
the more stable 1:1 p-TSA-TPPO co-crystal. The transformation from 3:2 to 1:1 p-TSA-
TPPO via temperature cycling was presented as a proof of concept approach to the control of 
crystalline form during co-crystallization, which prior to now was only been demonstrated for 
single component molecular systems. The study shows, for the first time the use of PAT to 
monitor the transformation events in a co-crystal system. The information was then used to 
aid the control of the co-crystallization process in order to obtain the desired crystalline form.  
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The semi-batch co-crystallization study was carried out using a fixed concentration of the 
two co-formers (p-TSA and TPPO) in MeCN, each prepared in a separate vessel. In this 
proof of concept study, the co-crystallization was controlled by changing the flow rate of the 
dissolved materials to the crystallizer. It was demonstrated that by changing the flow rates, 
the mass fraction of components sent to the crystallizer could be controlled, thereby 
controlling the outcome of the co-crystallization. This operation is promising, and could 
potentially be developed into a continuous co-crystallization process. 
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1. Selective co-crystallization of 1:1 and 3:2 stoichiometric forms of p-TSA-TPPO aided by an integrated array of 
process analytical technologies (PAT) and complemented by off-line solid-state analyses.  
 
 
2. Temperature cycling for based on in situ Raman spectroscopy signal for process control and use of PAT to 
gain understanding of solution mediated transformation events in the co-crystal system.  
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3. Control of a co-crystallisation process via differential flow rate of dissolved starting materials to the 
crystallizer. It was demonstrated that by changing the flow rates, the mass fraction of components to the 
crystallizer could be controlled, thereby controlling the co-crystal form obtained.  
 
